U.S. Genotyping Market Size, Share & Trends Analysis Report By Product (Instruments, Reagents & Kits), By Technology (PCR, Microarrays), By Application, By End-use, And Segment Forecasts, 2024 - 2030­

Table of Contents

Chapter 1. Methodology and Scope
                   1.1. Market Segmentation & Scope
                   1.2. Segment Definitions
                       1.2.1. Technology
                       1.2.2. Product
                       1.2.3. Application
                       1.2.4. End-use
                       1.2.5. Estimates and forecasts timeline
                   1.3. Research Methodology
                   1.4. Information Procurement
                       1.4.1. Purchased database
                       1.4.2. GVR’s internal database
                       1.4.3. Secondary sources
                       1.4.4. Primary research
                       1.4.5. Details of primary research
                           1.4.5.1. Data for primary interviews in U.S.
                   1.5. Information or Data Analysis
                       1.5.1. Data analysis models
                   1.6. Market Formulation & Validation
                   1.7. Model Details
                       1.7.1. Commodity flow analysis (Model 1)
                       1.7.2. Approach 1: Commodity flow approach
                   1.8. List of Secondary Sources
                   1.9. List of Primary Sources
                   1.10. Objectives
Chapter 2. Executive Summary
                   2.1. Market Outlook
                   2.2. Segment Outlook
                       2.2.1. Product Outlook
                       2.2.2. Technology Outlook
                       2.2.3. Application Outlook
                       2.2.4. End-use Outlook
                   2.3. Competitive Insights
Chapter 3. U.S. Genotyping Market Variables, Trends & Scope
                   3.1. Market Lineage Outlook
                       3.1.1. Parent market outlook
                       3.1.2. Related/ancillary market outlook
                   3.2. Market Dynamics
                       3.2.1. Market driver analysis
                           3.2.1.1. Rising prevalence of genetic and other target diseases
                           3.2.1.2. Increasing focus on development of target drugs and personalized medicine
                           3.2.1.3. Technological advancements in genotyping techniques
                           3.2.1.4. Increase in funding in genomics
                       3.2.2. Market restraint analysis
                           3.2.2.1. Lack of skilled labor
                           3.2.2.2. Ambiguous reimbursement policies
                   3.3. U.S. Genotyping Market Analysis Tools
                       3.3.1. Industry Analysis - Porter’s Five Forces
                           3.3.1.1. Threat of new entrant
                           3.3.1.2. Threat of substitues
                           3.3.1.3. Bargaining power of buyers
                           3.3.1.4. Bargaining power of suppliers
                           3.3.1.5. Competitive rivalry
                       3.3.2. PESTEL Analysis
                           3.3.2.1. Political & legal landscape
                           3.3.2.2. Economic landscape
                           3.3.2.3. Social landscape
                           3.3.2.4. Technological landscape
                           3.3.2.5. Environmental landscape
Chapter 4. U.S. Genotyping Market: Product Estimates & Trend Analysis
                   4.1. U.S. Genotyping Market: Product Dashboard
                   4.2. U.S. Genotyping Market: Product Movement Analysis
                   4.3. U.S. Genotyping Market Size & Forecasts and Trend Analyses, 2018 to 2030
                   4.4. Instruments
                       4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                   4.5. Reagents & Kits
                       4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                   4.6. Software and Services
                       4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 5. U.S. Genotyping Market: Technology Estimates & Trend Analysis
                   5.1. U.S. Genotyping Market: Technology Dashboard
                   5.2. U.S. Genotyping Market: Technology Movement Analysis
                   5.3. U.S. Genotyping Market Size & Forecasts and Trend Analyses, 2018 to 2030
                   5.4. PCR
                       5.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                   5.5. Capillary Electrophoresis
                       5.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                   5.6. Microarrays
                       5.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                   5.7. Sequencing
                       5.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                   5.8. Mass Spectrometry
                       5.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                   5.9. Others
                       5.9.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 6. U.S. Genotyping Market: Application Estimates & Trend Analysis
                   6.1. U.S. Genotyping Market: Application Dashboard
                   6.2. U.S. Genotyping Market: Application Movement Analysis
                   6.3. U.S. Genotyping Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
                   6.4. Pharmacogenomics
                       6.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                   6.5. Diagnostics and Personalized Medicine
                       6.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                   6.6. Agricultural Biotechnology
                       6.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                   6.7. Animal Genetics
                       6.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                   6.8. Others
                       6.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 7. U.S. Genotyping Market: End-use Estimates & Trend Analysis
                   7.1. U.S. Genotyping Market: End-use Dashboard
                   7.2. U.S. Genotyping Market: End-use Movement Analysis
                   7.3. U.S. Genotyping Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
                   7.4. Pharmaceutical and Biopharmaceutical Companies
                       7.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                   7.5. Diagnostics and Research Laboratories
                       7.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                   7.6. Academic Institutes
                       7.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                   7.7. Others
                       7.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 8. Competitive Landscape
                   8.1. Recent Developments & Impact Analysis, By Key Market Participants
                   8.2. Company/Competition Categorization
                   8.3. Vendor Landscape
                       8.3.1. List of key distributors and channel partners
                       8.3.2. Key customers
                       8.3.3. Key company market share analysis, 2023
                       8.3.4. Illumina Inc.
                           8.3.4.1. Company overview
                           8.3.4.2. Financial performance
                           8.3.4.3. Product benchmarking
                           8.3.4.4. Strategic initiatives
                       8.3.5. Thermo Fisher Scientific Inc.
                           8.3.5.1. Company overview
                           8.3.5.2. Financial performance
                           8.3.5.3. Product benchmarking
                           8.3.5.4. Strategic initiatives
                       8.3.6. QIAGEN
                           8.3.6.1. Company overview
                           8.3.6.2. Financial performance
                           8.3.6.3. Product benchmarking
                           8.3.6.4. Strategic initiatives
                       8.3.7. F. Hoffmann-La Roche Ltd.
                           8.3.7.1. Company overview
                           8.3.7.2. Financial performance
                           8.3.7.3. Product benchmarking
                           8.3.7.4. Strategic initiatives
                       8.3.8. Fluidigm Corporation
                           8.3.8.1. Company overview
                           8.3.8.2. Financial performance
                           8.3.8.3. Product benchmarking
                           8.3.8.4. Strategic initiatives
                       8.3.9. Danaher Corporation
                           8.3.9.1. Company overview
                           8.3.9.2. Financial performance
                           8.3.9.3. Product benchmarking
                           8.3.9.4. Strategic initiatives
                       8.3.10. Agilent Technologies
                           8.3.10.1. Company overview
                           8.3.10.2. Financial performance
                           8.3.10.3. Product benchmarking
                           8.3.10.4. Strategic initiatives
                       8.3.11. Eurofins Scientific Inc.
                           8.3.11.1. Company overview
                           8.3.11.2. Financial performance
                           8.3.11.3. Product benchmarking
                           8.3.11.4. Strategic initiatives
                       8.3.12. GE Healthcare Inc.
                           8.3.12.1. Company overview
                           8.3.12.2. Financial performance
                           8.3.12.3. Product benchmarking
                           8.3.12.4. Strategic initiatives
                       8.3.13. Bio-Rad Laboratories Inc.
                           8.3.13.1. Company overview
                           8.3.13.2. Financial performance
                           8.3.13.3. Product benchmarking
                           8.3.13.4. Strategic initiatives

List of Tables

Table 1. List of abbreviations
Table 2. U.S. Genotyping Market, by Product, 2018 - 2030 (USD Million)
Table 3. U.S. Genotyping Market, by Technology, 2018 - 2030 (USD Million)
Table 4. U.S. Genotyping Market, by Application, 2018 - 2030 (USD Million)
Table 5. U.S. Genotyping Market, by End-use, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 U.S. genotyping market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Value chain-based sizing & forecasting
Fig. 6 QFD modelling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Market snapshot
Fig. 9 End-use and end-use segment snapshot
Fig. 10 Sales channel and age segment snapshot
Fig. 11 Competitive landscape snapshot
Fig. 12 Market dynamics
Fig. 13 Porter’s Five Forces analysis
Fig. 14 PESTLE analysis
Fig. 15 U.S. genotyping market: Product outlook and key takeaways
Fig. 16 U.S. genotyping market: Product movement analysis
Fig. 17 Instruments market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 18 Reagents & kits market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 19 Software and services market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 20 U.S. genotyping market: Technology outlook and key takeaways
Fig. 21 U.S. genotyping market: Technology movement analysis
Fig. 22 PCR market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 23 Capillary electrophoresis market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 24 Microarrays market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 25 Sequencing market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 26 Mass spectrometry market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 27 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 28 U.S. genotyping market: Application outlook and key takeaways
Fig. 29 U.S. genotyping market: Application movement analysis
Fig. 30 Pharmacogenomics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 31 Diagnostics and personalized medicine market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 32 Agricultural biotechnology market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 33 Animal genetics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 34 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 35 U.S. genotyping market: End-use outlook and key takeaways
Fig. 36 U.S. genotyping market: End-use movement analysis
Fig. 37 Pharmaceutical and biopharmaceutical companies market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 38 Diagnostics and research laboratories market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 39 Academic institutes market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 40 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 41 Company market share analysis, 2023
Fig. 42 Strategic framework